Earnings History Data for Viking Therapeutics, Inc. (VKTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
23-10-2024	AH		VKTX	Viking Therapeutics, Inc.	7,130	-0.22	-0.24	-0.23	Viking Therapeutics GAAP EPS of -$0.22 beats by $0.03 [10/23/2024 4:14 PM]	72.69	12.30 (20.37%)	65.50	5.11 (8.46%)	8.28 - 99.41	15,512,203	2,100,000	111,365
Viking Therapeutics GAAP EPS of -$0.22 beats by $0.03 [10/23/2024 4:14 PM] Viking Therapeutics jumps as obesity updates outshine Q3 beat [10/24/2024 11:26 AM] Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [2024-10-23 04:05PM] Viking Therapeutics Inc (VKTX) Q3 2024 Earnings Call Highlights: Strong Financial Position Amid ... [2024-10-24 03:10AM] 3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia) [2024-10-24 08:20AM] Health and Wellness Industry Embraces Surge in Demand for Weight Loss Drugs [2024-10-24 09:17AM] Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet [2024-10-24 11:19AM] How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet [2024-10-24 09:48AM] Q3 2024 Viking Therapeutics Inc Earnings Call [2024-10-24 12:21PM]
24-07-2024	AH		VKTX	Viking Therapeutics, Inc.	5,700	-0.20	-0.26	-0.19	Viking Therapeutics GAAP EPS of -$0.20 beats by $0.07 [7/24/2024 4:15 PM]	64.89	14.48 (28.73%)	58.78	8.37 (16.60%)	8.28 - 99.41	19,220,182	2,900,000	505,033
Viking Therapeutics GAAP EPS of -$0.20 beats by $0.07 [7/24/2024 4:15 PM] Viking stock climbs 11% post-market on obesity drug update [7/24/2024 5:09 PM] Viking sends Lilly, Novo lower as obesity drug enters late-stage program [7/25/2024 7:01 AM] Biggest stock movers today: RTX, F, CMG, and more [7/25/2024 10:26 AM]
24-04-2024	AH		VKTX	Viking Therapeutics, Inc.	6,420	-0.26	-0.27	-0.25	Viking Therapeutics GAAP EPS of -$0.26 beats by $0.02 [4/24/2024 4:14 PM]	68.74	3.67 (5.64%)	63.35	-1.72 (-2.64%)	8.28 - 99.41	3,186,307	2,230,000	41,371
Viking Therapeutics down 4% despite quarterly bottom line beat [4/24/2024 6:25 PM] Viking Therapeutics GAAP EPS of -$0.26 beats by $0.02 [4/24/2024 4:14 PM]
07-02-2024	AH		VKTX	Viking Therapeutics, Inc.	2,470	-0.25	-0.25	-0.26	Viking Therapeutics GAAP EPS of -$0.25 beats by $0.01 [2/7/2024 4:09 PM]	28.88	4.40 (17.97%)	25.75	1.27 (5.19%)	8.28 - 29.45	7,889,669	2,800,000	84,556
Viking Therapeutics GAAP EPS of -$0.25 beats by $0.01 [2/7/2024 4:09 PM]
25-10-2023	AH		VKTX	Viking Therapeutics, Inc.	1,040	-0.23	-0.22	-0.21	Viking Therapeutics GAAP EPS of -$0.23 misses by $0.01 [10/25/2023 4:08 PM]	9.62	-1.05 (-9.84%)	9.05	-1.62 (-15.18%)	3.54 - 25.72	4,355,184	2,400,000	60,127
Viking Therapeutics GAAP EPS of -$0.23 misses by $0.01 [10/25/2023 4:08 PM]
26-07-2023	AH		VKTX	Viking Therapeutics, Inc.	1,440	-0.19	-0.21	-0.23	Viking Therapeutics GAAP EPS of -$0.19 in-line [7/26/2023 4:15 PM]	13.71	-0.57 (-4.03%)	13.62	-0.66 (-4.62%)	2.53 - 25.72	2,162,272	1,560,000	14,630
Viking Therapeutics GAAP EPS of -$0.19 in-line [7/26/2023 4:15 PM] Viking Therapeutics files for mixed shelf offering [7/26/2023 6:19 PM]
26-04-2023	AH	4:05 PM ET (Apr 26)	VKTX	Viking Therapeutics, Inc.	2,100	-0.25	-0.24	-0.21	Viking Therapeutics GAAP EPS of -$0.25 misses by $0.01 [4/26/2023 4:08 PM]	19.62	0.07 (0.38%)	20.24	0.69 (3.53%)	2.02 - 22.04	2,564,520	4,240,000	25,296
Viking Therapeutics GAAP EPS of -$0.25 misses by $0.01 [4/26/2023 4:08 PM]
08-02-2023	AH	4:05 PM ET (Feb 8)	VKTX	Viking Therapeutics, Inc.	697.87	-0.26	-0.23	-0.16	Viking Therapeutics GAAP EPS of -$0.26 misses by $0.03 [2/8/2023 4:22 PM]	10.68	1.12 (11.66%)	9.55	-0.01 (-0.10%)	2.02 - 11.08	4,360,097	1,590,000	6,410
Viking Therapeutics GAAP EPS of -$0.26 misses by $0.03 [2/8/2023 4:22 PM] Viking hits multi-year high after Q4 2022 earnings update [2/9/2023 3:00 PM]
26-10-2022	AH	4:05 PM ET (Oct 26)	VKTX	Viking Therapeutics, Inc.	309.82	-0.21	-0.23	-0.17	Viking Therapeutics GAAP EPS of -$0.21 beats by $0.02 [10/26/2022 4:30 PM]	4.06	-0.09 (-2.17%)	4.30	0.15 (3.61%)	2.02 - 7.05	695,535	1,450,000	899
Viking Therapeutics GAAP EPS of -$0.21 beats by $0.02 [10/26/2022 4:30 PM]
27-07-2022	AH	4:10 PM ET (Jul 27)	VKTX	Viking Therapeutics, Inc.	261.52	-0.23	-0.21	-0.20	Viking Therapeutics GAAP EPS of -$0.23 misses by $0.02 [7/27/2022 4:33 PM]	3.19	0.02 (0.47%)	3.20	0.02 (0.63%)	2.02 - 7.20	763,879	1,140,000	1,265
Viking Therapeutics GAAP EPS of -$0.23 misses by $0.02 [7/27/2022 4:33 PM] Viking Therapeutics (VKTX) Q2 2022 Earnings Call Transcript [Jul-28-22 12:30AM] Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Jul-27-22 04:05PM]
27-04-2022	AH	4:05 PM ET (Apr 27)	VKTX	Viking Therapeutics, Inc.	190.34	-0.21	-0.20	-0.19	Viking Therapeutics GAAP EPS of -$0.21 misses by $0.02 [4/27/2022 4:11 PM]	2.39	0.19 (8.64%)	2.19	-0.01 (-0.45%)	2.15 - 7.20	873,981	1,010,000	1,179
Viking Therapeutics GAAP EPS of -$0.21 misses by $0.02 [4/27/2022 4:11 PM] Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update [Apr-27-22 04:08PM] Viking Therapeutics (VKTX) Q1 2022 Earnings Call Transcript [Apr-28-22 12:30AM]
09-02-2022	AH	4:05 PM ET (Feb 9)	VKTX	Viking Therapeutics, Inc.	277.73	-0.16	-0.19	-0.15	Viking Therapeutics GAAP EPS of -$0.16 beats by $0.03 [2/9/2022 4:08 PM]	4.05	0.32 (8.58%)	3.80	0.07 (1.88%)	3.21 - 9.41	1,887,904	1,180,000	12,084
Viking Therapeutics GAAP EPS of -$0.16 beats by $0.03 [2/9/2022 4:08 PM] Viking Therapeutics rises 8% following Q4 results [2/10/2022 11:44 AM] Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update [Feb-09-22 04:05PM] Viking Therapeutics (VKTX) Q4 2021 Earnings Call Transcript [Feb-10-22 02:31AM] 3 Biotech Stocks That Are too Cheap to Ignore [Feb-10-22 03:36PM]
03-11-2021	AH	4:05 PM ET (Nov 3)	VKTX	Viking Therapeutics, Inc.	480.09	-0.17	-0.21	-0.13	Viking Therapeutics EPS beats by $0.04 [11/3/2021 4:10 PM]	6.72	0.14 (2.13%)	6.72	0.0 (0.00%)	4.95 - 10.09	1,209,543	640,000	3,487
Viking Therapeutics EPS beats by $0.04 [11/3/2021 4:10 PM] How Much Upside is Left in Viking Therapeutics, Inc. (VKTX)? Wall Street Analysts Think 204% [Nov-02-21 09:10AM] Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-03-21 04:05PM] Viking Therapeutics (VKTX) Q3 2021 Earnings Call Transcript [Nov-04-21 03:31AM]
28-07-2021	AH	4:05 PM ET (Jul 28)	VKTX	Viking Therapeutics, Inc.	439.70	-0.20	-0.19	-0.13	Viking Therapeutics EPS in-line [7/28/2021 4:12 PM]	6.07	0.22 (3.67%)	5.94	0.08 (1.37%)	4.95 - 10.09	677,962	560,000	5,431
Viking Therapeutics EPS in-line [7/28/2021 4:12 PM] Viking Therapeutics shares fall after wider Q2 net loss [7/28/2021 5:00 PM] 89bio and Viking Therapeutics become BTIG’s top picks in NASH space [7/29/2021 2:09 PM] Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Jul-28-21 04:05PM] Viking Therapeutics (VKTX) Q2 2021 Earnings Call Transcript [Jul-29-21 08:02PM]
28-04-2021	AH	4:05 PM ET (Apr 28)	VKTX	Viking Therapeutics, Inc.	486.22	-0.19	-0.18	-0.13	Viking Therapeutics EPS misses by $0.02 [4/28/2021 4:16 PM]	6.26	-0.10 (-1.57%)	6.26	0.0 (0.00%)	5.22 - 10.09	805,754	830,000	4,245
Viking Therapeutics EPS misses by $0.02 [4/28/2021 4:16 PM] We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth [Apr-27-21 08:30AM] Viking Therapeutics, Inc. to Host Earnings Call [Apr-28-21 02:30PM] Viking Therapeutics (VKTX) Q1 2021 Earnings Call Transcript [Apr-29-21 12:31AM] Viking Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update [Apr-28-21 04:05PM]
17-02-2021	AH	4:05 PM ET (Feb 17)	VKTX	Viking Therapeutics, Inc.	612.07	-0.15	-0.15	-0.10	Viking Therapeutics EPS in-line [2/17/2021 4:10 PM]	7.57	-0.70 (-8.48%)	8.30	0.03 (0.36%)	3.26 - 10.09	1,475,439	2,279,494	16,440
Viking Therapeutics EPS in-line [2/17/2021 4:10 PM] Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update [Feb-17-21 04:05PM] Viking Therapeutics, Inc. to Host Earnings Call [Feb-17-21 02:30PM]
28-10-2020	AH	4:05 PM ET (Oct 28)	VKTX	Viking Therapeutics, Inc.	405.99	-0.13	-0.15	-0.08	Viking Therapeutics EPS beats by $0.02 [10/28/2020 4:15 PM]	5.58	0.28 (5.28%)	5.35	0.05 (0.94%)	3.26 - 8.87	1,982,966	1,038,187	9,359

29-07-2020	AH	4:05 PM ET (Jul 29)	VKTX	Viking Therapeutics, Inc.	504.55	-0.13	-0.14	-0.11	Viking Therapeutics EPS beats by $0.01 [7/29/2020 4:10 PM]	7.51	0.90 (13.62%)	6.70	0.09 (1.36%)	3.26 - 8.87	1,859,823	915,608	17,851